Adrienne Chagoly
Adult Health · Cedar Park, TXNPI 1366597304
Payments from drug & device makers
Across 193 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$640
- Insulet Corporation$331
- Lilly USA, LLC$320
- AstraZeneca$283
- Abbott$263
- Medtronic$250
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,78099%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 25 | $640 |
| Insulet Corporation | 7 | $331 |
| Lilly USA, LLC | 19 | $320 |
| AstraZeneca(2 entities) | 12 | $283 |
| Abbott | 18 | $263 |
| Medtronic | 14 | $250 |
| Corcept Therapeutics | 18 | $246 |
| Dexcom, Inc. | 13 | $219 |
| Boehringer Ingelheim | 8 | $193 |
| Novo Nordisk | 9 | $156 |
| Sanofi-aventis U.S. LLC | 8 | $137 |
| Amgen | 6 | $95 |
| Xeris Pharmaceuticals, Inc. | 5 | $89 |
| Radius Health, Inc. | 3 | $65 |
| Averitas Pharma Inc. | 4 | $64 |
| BETA Bionics, Inc. | 3 | $52 |
| Cequr Corporation | 1 | $50 |
| Novartis | 2 | $49 |
| Bayer | 3 | $48 |
| Recordati_rare_diseases_inc. | 2 | $42 |
| IBSA Pharma Inc. | 2 | $31 |
| GRT US Holding, Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 1 | $23 |
| Halozyme Inc | 1 | $21 |
| AbbVie | 1 | $20 |
| Vivus LLC | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Mannkind Corporation | 1 | $14 |
| Intuity Medical Inc | 1 | $13 |
| Vistapharm, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$109
How this compares
$3,805 in reported general payments places this provider in the 85th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 183 | $215,239 |
| MounjaroTirzepatide | 120 | $158,807 |
| JardianceEmpagliflozin | 135 | $106,515 |
| TrulicityDulaglutide | 40 | $62,185 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $52,529 |
| JanuviaSitagliptin Phosphate | 52 | $50,755 |
| FarxigaDapagliflozin Propanediol | 54 | $46,628 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 80 | $46,239 |
| ProliaDenosumab | 21 | $34,754 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 20 | $32,619 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 29 | $30,968 |
| Xigduo XrDapaglifloz Propaned/Metformin | 18 | $22,622 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $21,013 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $20,578 |
| Tresiba Flextouch U-100Insulin Degludec | 33 | $16,264 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $320 | $230,345206 claims |
| Novo NordiskOzempic, Novolog | $156 | $221,804204 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $193 | $137,483164 claims |
| AstraZenecaFarxiga | $283 | $46,62854 claims |
| AmgenProlia | $95 | $34,75421 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $137 | $32,61920 claims |
| AbbVieSynthroid | $20 | $6,28383 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $16 | $3,349282 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 933 adult health providers in Texas.
Other adult health in Cedar Park
- Misty SheddAllen$863K
- Melodie YoungDallas$700K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Eric KlappholzDallas$44K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
- Meghan MurphyAustin$29K
- Sandra CareyGrapevine$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.